CervoMed, Inc. (CRVO)
2.44
+0.01
(+0.41%)
USD |
NASDAQ |
Sep 21, 16:00
2.44
0.00 (0.00%)
After-Hours: 20:00
CervoMed Market Cap : 33.00M for Sept. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 32.87M |
| September 17, 2026 | 34.49M |
| September 16, 2026 | 33.00M |
| September 15, 2026 | 33.14M |
| September 14, 2026 | 34.22M |
| September 11, 2026 | 34.76M |
| September 10, 2026 | 33.54M |
| September 09, 2026 | 33.95M |
| September 08, 2026 | 34.22M |
| September 04, 2026 | 34.63M |
| September 03, 2026 | 34.36M |
| September 02, 2026 | 35.71M |
| September 01, 2026 | 34.76M |
| August 31, 2026 | 35.57M |
| August 28, 2026 | 35.17M |
| August 27, 2026 | 35.71M |
| August 26, 2026 | 35.84M |
| August 25, 2026 | 35.84M |
| August 24, 2026 | 35.57M |
| August 21, 2026 | 35.44M |
| August 20, 2026 | 34.63M |
| August 19, 2026 | 36.66M |
| August 18, 2026 | 35.30M |
| August 17, 2026 | 35.30M |
| August 14, 2026 | 36.93M |
| Date | Value |
|---|---|
| August 13, 2026 | 39.63M |
| August 12, 2026 | 41.53M |
| August 11, 2026 | 41.80M |
| August 10, 2026 | 38.68M |
| August 07, 2026 | 38.82M |
| August 06, 2026 | 37.33M |
| August 05, 2026 | 38.01M |
| August 04, 2026 | 25.92M |
| August 03, 2026 | 24.07M |
| July 31, 2026 | 23.89M |
| July 30, 2026 | 23.33M |
| July 29, 2026 | 22.96M |
| July 28, 2026 | 23.70M |
| July 27, 2026 | 24.63M |
| July 24, 2026 | 24.63M |
| July 23, 2026 | 24.72M |
| July 22, 2026 | 25.74M |
| July 21, 2026 | 26.76M |
| July 20, 2026 | 25.83M |
| July 17, 2026 | 28.52M |
| July 16, 2026 | 29.07M |
| July 15, 2026 | 28.42M |
| July 14, 2026 | 28.52M |
| July 13, 2026 | 30.65M |
| July 10, 2026 | 33.05M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.543B |
| Alnylam Pharmaceuticals, Inc. | 32.66B |
| Anika Therapeutics, Inc. | 277.30M |
| Savara, Inc. | 1.120B |
| Vericel Corp. | 2.023B |
Market Cap Related Metrics
| PS Ratio | 69.98 |
| PEG Ratio | -0.0327 |
| Price to Book Value | 1.437 |
| Price | 2.44 |
| Earnings Yield | -131.6% |
| PEGY Ratio | -0.0327 |